Product Information
CLOBETASOL 0.05% SOLUTION is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1359 per ML under NDC 62332048650. Its NADAC has been published 343 times since Mar 11, 2020.
FDA first approved this application on Oct 21, 2019. Its Orange Book therapeutic-equivalence code is AT.
Strength
.5 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332048650
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA212881FDA Approved
10/21/2019
TE Code
AT
On Market Since
10/24/2019
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% SOLUTION has been published 343 times since Mar 11, 2020, and over the history we have for it it has declined 80.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1359 per ML |
|---|---|
| All-time high | $0.7391 (May 13, 2020) |
| All-time low | $0.1149 (May 20, 2026) |
| 52-week high | $0.1829 |
| 52-week low | $0.1149 |
| Median price | $0.2771 |
| Average price | $0.3085 |
| Largest weekly change | +42.8% (Feb 22, 2023) |
| Weeks tracked | 343 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLOBETASOL PROPIONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% SOLUTION, manufactured by Alembic Pharmaceuticals Inc., is $0.1359 per ML (NDC 62332048650), effective Sep 30, 2026.
How has the price of CLOBETASOL 0.05% SOLUTION changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% SOLUTION has declined 80.6%. It has been tracked across 343 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% SOLUTION?
Since Mar 11, 2020, the NADAC for CLOBETASOL 0.05% SOLUTION has ranged from a low of $0.1149 (May 20, 2026) to a high of $0.7391 (May 13, 2020), with a median of $0.2771 per ML.
Are there cheaper alternatives to CLOBETASOL 0.05% SOLUTION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOBETASOL 0.05% SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOBETASOL 0.05% SOLUTION?
CLOBETASOL 0.05% SOLUTION (NDC 62332048650) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.